Platelet Reactivity in Patients With a History of Obstructive Prosthetic Valve Thrombosis

American Journal of Cardiology

Volumn 103, Issue 12, 2009, Pages 1760-1763

  Bouganim, Tal ^a   Shapira, Yaron ^a   Sagie, Alexander ^a   Vaturi, Mordehay ^a   Battler, Alexander ^a   Kornowski, Ran ^a   Lev, Eli I ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CD40 LIGAND; COLLAGEN; PADGEM PROTEIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FIBRINOLYTIC THERAPY; GENDER; HEART VALVE REPLACEMENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; PROTEIN BLOOD LEVEL; SMOKING; STANDARD; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS; THROMBOGENICITY; THROMBOSIS PREVENTION;

CD40 LIGAND; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PROGNOSIS; RETROSPECTIVE STUDIES; THROMBOSIS; TIME FACTORS;

EID: 67649397412     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.02.031     Document Type: Article

References (12)

1. Bonow R.O., Carabello B.A., Chatterjee K., de Leon Jr. A.C., Faxon D.P., Freed M.D., Gaasch W.H., Lytle B.W., Nishimura R.A., O'Gara P.T., O'Rourke R.A., Otto C.M., Shah P.M., Shanewise J.S., and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol 52 (2008) 1-142
2. Shapira Y., Herz I., Vaturi M., Porter A., Adler Y., Birnbaum Y., Strasberg B., Sclarovsky S., and Sagie A. Thrombolysis is an effective and safe therapy in stuck bileaflet mitral valves in the absence of high-risk thrombi. J Am Coll Cardiol 35 (2000) 1874-1880
3. Shenkman B., Savion N., Dardik R., Tamarin I., and Varon D. Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor. Thromb Res 99 (2000) 353-361
4. Becker R.C., Eisenberg P., and Turpie A.G. Pathobiologic features and prevention of thrombotic complications associated with prosthetic heart valves: fundamental principles and the contribution of platelets and thrombin. Am Heart J 141 (2001) 1025-1037
5. Courtney J.M., and Forbes C.D. Thrombosis on foreign surfaces. Br Med Bull 50 (1994) 966-981
6. Forbes C.D. Thrombosis and artificial surfaces. Clin Haematol 10 (1981) 653-668
7. Schlitt A., Hauroeder B., Buerke M., Peetz D., Victor A., Hundt F., Bickel C., Meyer J., and Rupprecht H.J. Effects of combined therapy of clopidogrel and aspirin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model. Thromb Res 107 (2002) 39-43
8. Laffort P., Roudaut R., Roques X., Lafitte S., Deville C., Bonnet J., and Baudet E. Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude Medical prosthesis: a clinical and transesophageal echocardiographic study. J Am Coll Cardiol 35 (2000) 739-746
9. Turpie A.G., Gent M., Laupacis A., Latour Y., Gunstensen J., Basile F., Klimek M., and Hirsh J. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 329 (1993) 524-529
10. Cappelleri J.C., Fiore L.D., Brophy M.T., Deykin D., and Lau J. Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: a meta-analysis. Am Heart J 130 (1995) 547-552
11. Massel D., and Little S.H. Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis. J Am Coll Cardiol 37 (2001) 869-878
12. Meschengieser S.S., Fondevila C.G., Frontroth J., Sandarelli M.T., and Lazzari M.A. Low-intensity oral anticoagulation plus low dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical heart valves. J Thorac Cardiovasc Surg 113 (1997) 910-916